Bjerkeli V - Search Results

1

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.

Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L, Seljeflot I, Aukrust P, Osnes L, Dahl TB. Huse C, et al. Among authors: bjerkeli v. EBioMedicine. 2022 Jun;80:104013. doi: 10.1016/j.ebiom.2022.104013. Epub 2022 Apr 30. EBioMedicine. 2022. PMID: 35504178 Free PMC article.

2

Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.

Hestdal K, Aukrust P, Müller F, Lien E, Bjerkeli V, Espevik T, Frøland SS. Hestdal K, et al. Among authors: bjerkeli v. Blood. 1997 Oct 1;90(7):2670-9. Blood. 1997. PMID: 9326234 Free article.

3

Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordøy I, Espevik T, Müller F, Frøland SS. Aukrust P, et al. Among authors: bjerkeli v. J Infect Dis. 1997 Oct;176(4):913-23. doi: 10.1086/516510. J Infect Dis. 1997. PMID: 9333149 Clinical Trial.

4

Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.

Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P. Damås JK, et al. Among authors: bjerkeli v. Cardiovasc Res. 2000 Sep;47(4):778-87. doi: 10.1016/s0008-6363(00)00142-5. Cardiovasc Res. 2000. PMID: 10974226

5

Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure.

Eiken HG, Øie E, Damås JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tønnessen T, Christensen G, Frøland SS, Gullestad L, Attramadal H, Aukrust P. Eiken HG, et al. Among authors: bjerkeli v. Eur J Clin Invest. 2001 May;31(5):389-97. doi: 10.1046/j.1365-2362.2001.00795.x. Eur J Clin Invest. 2001. PMID: 11380590

6

Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients.

Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damås JK, Haug T, Eiken HG, Aukrust P, Frøland SS. Stylianou E, et al. Among authors: bjerkeli v. Clin Exp Immunol. 2002 Nov;130(2):279-85. doi: 10.1046/j.1365-2249.2002.01980.x. Clin Exp Immunol. 2002. PMID: 12390316 Free PMC article.

7

Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients.

Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås JK, Aukrust P, Frøland SS. Stylianou E, et al. Among authors: bjerkeli v. Clin Exp Immunol. 2003 Jun;132(3):462-6. doi: 10.1046/j.1365-2249.2003.02179.x. Clin Exp Immunol. 2003. PMID: 12780693 Free PMC article.

8

Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP.

Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Frøland SS, Aukrust P, Taskén K. Johansson CC, et al. Among authors: bjerkeli v. AIDS. 2004 Jan 23;18(2):171-9. doi: 10.1097/00002030-200401230-00005. AIDS. 2004. PMID: 15075533

9

Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.

Bjerkeli V, Halvorsen B, Damås JK, Nordøy I, Yndestad A, Aukrust P, Frøland SS. Bjerkeli V, et al. Ann Rheum Dis. 2004 Dec;63(12):1659-63. doi: 10.1136/ard.2003.017954. Ann Rheum Dis. 2004. PMID: 15547092 Free PMC article.

10

Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro.

Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Frøland SS. Torheim EA, et al. Among authors: bjerkeli v. Clin Exp Immunol. 2005 May;140(2):376-83. doi: 10.1111/j.1365-2249.2005.02770.x. Clin Exp Immunol. 2005. PMID: 15807865 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page